Exhibit 31.1 CERTIFICATION                 I, Kelly T. Hickel, Chief Executive Officer of TheraBiogen, Inc.        (the "Company" or "Registrant) certify that:                 1. I have reviewed this quarterly report on Form 10-Q of the Company;                 2. Based on my knowledge, this quarterly report does not contain any untruestatement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;                 3. Based on my knowledge, the financial statements, and other financial        information included in this quarterly report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theRegistrant as of, and for, the periods presented in this quarterly report;                 4. The registrant's other certifying officers and I are responsible for        establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:                 (a) Designed such disclosure controls and procedures, or        caused such disclosure controls and procedures to be designedundermy supervision, to ensure that material informationrelating to theregistrant, is made known to us by others withinCompany, particularly during the period in which this report isbeing prepared;        (b) Designed such internal control over financial        reporting, or caused such internal control over financialreporting to be designed under our supervision, to providereasonable assuranceregarding the reliability of financialreporting and the preparation of financial statements forexternal purposes in accordance with generally acceptedaccounting principles;        (c) Evaluated the effectiveness of the registrant's        disclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered bythis report based on such evaluation; and        (d) Disclosed in this report any change in theregistrant'sinternal control over financial reporting thatoccurred during theCompany's fourth fiscal quarter that hasmaterially affected, or isreasonably likely to materially        affect, the Company's internal control over financial reporting; and                 5. The Registrant's other certifying officers and I have disclosed, based onour most recent evaluation, to the registrant's auditors and the audit        committee of registrant's board of directors (or persons performing the        equivalent function):                 a. all significant deficiencies in the design or operation of internalcontrols which could adversely affect the registrant's ability torecord, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internalcontrols;        and        b. any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant's internal        controls; and                 6. The Registrant's other certifying officers and I have indicated in thisannual report whether or not there were significant changes in internalcontrols or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.                          Date:August 14, 2009/s/ Kelly T. Hickel        -----------------------------        Kelly T. Hickel,        Chief Executive Officer